AzTrials
AzTrials

Cervical CancerNCT06705309

Web-Based Education Program and Educational Booklet Developed on Cervıcal Cancer

A study testing Web-Based Education in people with Cervical Cancer, run by Istanbul University - Cerrahpasa at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Cervical cancer is the fourth most common cancer type among women worldwide and ranks ninth in Turkey, making it the second most common gynecological cancer. The prevention of cancer heavily relies on identifying risk factors, implementing preventive measures, and early diagnosis. Read more about this study

Who is it for?
Ages 30 to 65 years, women onlyHealthy volunteers can take part
Conditions the study is for
Cervical Cancer
What is being tested?
Web-Based Education
Could I receive a placebo?
No, everyone receives an active treatment
How many people
128 participants
Where
1 siteTurkey (Türkiye)
Study dates
29 May 2024to 21 Nov 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 30 to 65 years
  • Women only
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Being between the ages of 30-65,
  • Having never had a cervical cancer screening before,
  • Having received training on cervical cancer,
  • There is no obstacle to answering the questions physically, mathematically or spiritually,
  • Having internet access,
  • Being able to use a computer and/or tablet effectively,
Show all 9Show fewer
  • Academicians working in health programs,
  • Healthy female academics who did not agree to participate in the research,
  • Being able to use a computer

Who cannot join

  • The emergence of any health problem that prevents the person from continuing the research,
  • Not completing any of the required forms,
  • Those who give up participating in the study at any stage of the study
  • Do not visit 80% of the tabs in the web training program,
  • Those who have never read the training booklet will be excluded.

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Istanbul University - Cerrahpasa

    Avcılar, 34320

Other trials in Turkey (Türkiye)

About this study

Official title: The Effect of a Web-Based Education Program and Educational Booklet Developed on Cervıcal Cancer on Women's Prevention Methods

Cervical cancer is the fourth most common cancer type among women worldwide and ranks ninth in Turkey, making it the second most common gynecological cancer. The prevention of cancer heavily relies on identifying risk factors, implementing preventive measures, and early diagnosis. Cervical cancer is associated with high-risk Human Papilloma Virus (HPV) infections, transmitted primarily through sexual contact, accounting for 99.7% of cases. Risk-enhancing factors include early sexual activity, poor hygiene, low socioeconomic status, and immunosuppressive conditions. The World Health Organization (WHO) launched the "Cervical Cancer Elimination Program" to address this public health issue, aiming for 90% of girls to be vaccinated against HPV by age 15, 70% of women aged 35-45 to be screened, and 90% of women diagnosed with cancer to have access to treatment by 2030. The low participation rate in cervical cancer screening programs in Turkey highlights the urgent need to increase public awareness. Web-based education is an effective tool for promoting health behaviors and increasing awareness. Its cost-effectiveness, ability to reach large audiences, and easy accessibility make it a valuable resource in healthcare. Studies in the literature demonstrate that web-based and video-based education significantly enhance cervical cancer awareness and encourage pap smear test uptake. This study developed a web-based education program and an educational booklet on cervical cancer, based on the Health Belief Model, to evaluate their impact on women's knowledge, attitudes, and behaviors. The study aims to contribute to the dissemination of cervical cancer prevention methods and enrich the existing literature.

Read the detailed description

Cervical cancer is the fourth most common cancer among women worldwide and ranks ninth in Turkey, making it the second most common gynecological cancer. This highlights the significance of cervical cancer both globally and within Turkey. The prevention of this cancer is heavily reliant on identifying risk factors, implementing effective preventive measures, and ensuring early diagnosis. These factors play a crucial role in reducing the incidence of cervical cancer and improving the outcomes for affected individuals.

Cervical cancer is primarily associated with high-risk Human Papilloma Virus (HPV) infections, which are transmitted mainly through sexual contact. In fact, 99.7% of cervical cancer cases are linked to HPV infection. Understanding the risk factors for HPV and cervical cancer is essential for prevention. These risk-enhancing factors include early sexual activity, poor hygiene practices, low socioeconomic status, and immunosuppressive conditions, such as HIV infection or the use of immunosuppressive drugs.

To tackle this significant public health issue, the World Health Organization (WHO) launched the "Cervical Cancer Elimination Program," which sets ambitious goals to reduce the burden of cervical cancer by 2030. These goals include 90% of girls vaccinated against HPV by age 15, 70% of women aged 35-45 screened for cervical cancer, and 90% of women diagnosed with cervical cancer to have access to treatment. These targets are part of a broader effort to eliminate cervical cancer as a public health problem, aiming for a world where the incidence of cervical cancer is significantly reduced through vaccination, screening, and treatment accessibility.

Despite global efforts, there is a low participation rate in cervical cancer screening programs in Turkey, highlighting the urgent need to increase public awareness about the importance of early detection. Increasing awareness through educational campaigns can improve participation and, in turn, help reduce the incidence of cervical cancer.

Web-based education is increasingly recognized as an effective tool for promoting health behaviors and raising awareness on various health topics. Its key advantages include cost-effectiveness, accessibility, and convenience. Web-based programs are generally more affordable than in-person interventions and can reach a wide audience, including individuals who may not have easy access to healthcare facilities. Participants can engage with the content at their own pace, making it an attractive option for health education.

Studies have shown that web-based and video-based education can significantly enhance awareness about cervical cancer and encourage women to undergo preventive screenings, such as the Pap smear test, which is crucial for early detection.

The study developed a web-based education program and an educational booklet on cervical cancer, grounded in the Health Belief Model. This model focuses on individuals' perceptions of health risks and the benefits of taking preventive actions. The study aims to evaluate the impact of these educational tools on women's knowledge, attitudes, and behaviors regarding cervical cancer prevention. By assessing the effectiveness of these educational resources, the study aims to contribute to the dissemination of cervical cancer prevention methods and enrich the existing literature on the topic.

This research aims to provide valuable insights into how web-based education and educational booklets can be used to improve women's understanding of cervical cancer and enhance preventive behaviors. By contributing to public awareness and facilitating access to information, this study supports global and national efforts to reduce the burden of cervical cancer.

Conditions
Cervical Cancer
Being tested
Web-Based Education
Keywords
Cervical Cancer Awareness, Prevention, HPV, Pap Smear
Medical subject headings
Uterine Cervical Neoplasms, Papillomavirus Infections

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Web-Based EducationBehavioural

    The Effect of a Web-Based Education Program and Educational Booklet Developed on Cervıcal Cancer on Women's Prevention Methods

Study groups in NCT06705309
Study groupRoleWhat they receive
Web-Based Education GroupExperimentalWeb-Based Education Group
Receives: Behavioral: Web-Based Education

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The Effect of a Web-Based Education Program and Educational Booklet Developed on Cervical Cancer on Women's Prevention Methods

    To develop a web-based education program and an educational booklet on cervical cancer, and to assess the effectiveness of this program and booklet in improving women's knowledge, attitudes, and behaviors regarding cervical cancer prevention. The evaluation will be based on pre- and post-intervention surveys measuring changes in participants' understanding of cervical cancer, their attitudes toward screening and prevention, and their behaviors related to cervical cancer prevention practices.

    Measured: 1.5 year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Nov 2024
  2. Study start29 May 2024
  3. Primary completion31 Aug 2024
  4. Study completion21 Nov 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
128 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06705309
Sponsor's protocol ID
Istanbul UniversityC
Status last verified
Nov 2024
First submitted
21 Nov 2024
Last updated
26 Nov 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Web-Based Education in people with Cervical Cancer, run by Istanbul University - Cerrahpasa at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 9 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 26 Nov 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The Effect of a Web-Based Education Program and Educational Booklet Developed on Cervical Cancer on Women's Prevention Methods (time frame: 1.5 year). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Nov 2024.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in